Role of fibronectin in Pneumocystis carinii attachment to cultured lung cells.

Activity of bilobalide, a sesquiterpene from Ginkgo biloba, on Pneumocystis carinii. Antimicrob Agents Chemother (1993) 1.54

120-kD surface glycoprotein of Pneumocystis carinii is a ligand for surfactant protein A. J Clin Invest (1992) 1.53

Pneumocystis carinii, an opportunist in immunocompromised patients. Clin Microbiol Rev (1991) 1.47

Internalization of Aspergillus fumigatus conidia by epithelial and endothelial cells. Infect Immun (1997) 1.34

Pneumocystis carinii attachment to cultured lung cells by pneumocystis gp 120, a fibronectin binding protein. J Clin Invest (1991) 1.29

Vitronectin binds to Pneumocystis carinii and mediates organism attachment to cultured lung epithelial cells. Infect Immun (1993) 1.28

Purification and characterization of a major human Pneumocystis carinii surface antigen. J Clin Invest (1991) 1.25

Pneumocystis carinii activates the NF-kappaB signaling pathway in alveolar epithelial cells. Infect Immun (2005) 1.24

Surfactant protein D interacts with Pneumocystis carinii and mediates organism adherence to alveolar macrophages. J Clin Invest (1995) 1.24

Pneumocystis carinii glycoprotein A binds macrophage mannose receptors. Infect Immun (1995) 1.18

Mechanism of Pneumocystis carinii attachment to cultured rat alveolar macrophages. J Clin Invest (1990) 1.17

Genetics of surface antigen expression in Pneumocystis carinii. Infect Immun (2001) 1.15

Isolation and characterization of a recombinant antigen of Pneumocystis carinii. Infect Immun (1992) 0.98

Pseudomonas aeruginosa strains possess specific adhesins for laminin. Infect Immun (1996) 0.93

Gamma interferon stimulates rat alveolar macrophages to kill Pneumocystis carinii by L-arginine- and tumor necrosis factor-dependent mechanisms. Infect Immun (1999) 0.93

Gene for an extracellular matrix receptor protein from Pneumocystis carinii. Proc Natl Acad Sci U S A (1994) 0.91

Pneumocystis carinii attachment increases expression of fibronectin-binding integrins on cultured lung cells. Infect Immun (1994) 0.87

Fibronectin facilitates Mycobacterium tuberculosis attachment to murine alveolar macrophages. Infect Immun (2002) 0.86

Cellular responses to a 55-kilodalton recombinant Pneumocystis carinii antigen. Infect Immun (1994) 0.86

Effect of bronchoalveolar lavage fluid from Pneumocystis carinii-infected hosts on phagocytic activity of alveolar macrophages. Infect Immun (2004) 0.85

The major surface glycoprotein of Pneumocystis carinii induces release and gene expression of interleukin-8 and tumor necrosis factor alpha in monocytes. Infect Immun (1997) 0.84

The lipids of Pneumocystis carinii. Clin Microbiol Rev (1998) 0.84

Identification of a putative precursor to the major surface glycoprotein of Pneumocystis carinii. Infect Immun (1998) 0.84

The Pneumocystis Ace2 transcription factor regulates cell wall-remodeling genes and organism virulence. J Biol Chem (2013) 0.82

Host cell invasion by medically important fungi. Cold Spring Harb Perspect Med (2014) 0.79

Pneumocystis carinii interactions with lung epithelial cells and matrix proteins induce expression and activity of the PcSte20 kinase with subsequent phosphorylation of the downstream cell wall biosynthesis kinase PcCbk1. Infect Immun (2011) 0.78

Characterization of a novel ADAM protease expressed by Pneumocystis carinii. Infect Immun (2009) 0.76

Steady-state effects of vitronectin and fibronectin on the binding, uptake, and degradation of Pneumocystis carinii in rat alveolar macrophages. Inflammation (1997) 0.76

New perspectives in cell adhesion: RGD and integrins. Science (1987) 18.41

Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule. Nature (1984) 14.25

Fibronectin and its receptors. Annu Rev Biochem (1988) 7.06

Structure of integrin, a glycoprotein involved in the transmembrane linkage between fibronectin and actin. Cell (1986) 5.29

Variants of the cell recognition site of fibronectin that retain attachment-promoting activity. Proc Natl Acad Sci U S A (1984) 5.13

A 125/115-kDa cell surface receptor specific for vitronectin interacts with the arginine-glycine-aspartic acid adhesion sequence derived from fibronectin. Proc Natl Acad Sci U S A (1985) 4.44

Fibronectin binds to Staphylococcus aureus. Nature (1978) 4.39

Binding and factor XIIIa-mediated cross-linking of a 27-kilodalton fragment of fibronectin to Staphylococcus aureus. Science (1980) 3.68

Location of the cell-attachment site in fibronectin with monoclonal antibodies and proteolytic fragments of the molecule. Cell (1981) 3.64

Molecular biology of fibronectin. Annu Rev Cell Biol (1985) 3.39

Adherence of group A streptococci to fibronectin on oral epithelial cells. Infect Immun (1983) 3.11

The interaction in vitro of Pneumocystis carinii with macrophages and L-cells. J Exp Med (1978) 2.93

The effect of Arg-Gly-Asp-containing peptides on fibrinogen and von Willebrand factor binding to platelets. Proc Natl Acad Sci U S A (1985) 2.64

Cultivation of Pneumocystis carinii with WI-38 cells. J Clin Microbiol (1979) 2.63

Fibronectin binding to Staphylococcus aureus. J Biol Chem (1982) 2.54

Production of fibronectin by the human alveolar macrophage: mechanism for the recruitment of fibroblasts to sites of tissue injury in interstitial lung diseases. Proc Natl Acad Sci U S A (1981) 2.34

Fibronectin mediates Treponema pallidum cytadherence through recognition of fibronectin cell-binding domain. J Exp Med (1985) 2.32

Detachment of cells from culture substrate by soluble fibronectin peptides. J Cell Biol (1985) 2.26

New rat model of Pneumocystis carinii infection. J Clin Microbiol (1988) 2.21

Physiology of fibronectin. Annu Rev Med (1984) 2.17

The tetrapeptide analogue of the cell attachment site of fibronectin inhibits platelet aggregation and fibrinogen binding to activated platelets. J Biol Chem (1985) 1.91

Analyses of rat Pneumocystis carinii antigens recognized by human and rat antibodies by using western immunoblotting. Infect Immun (1986) 1.81

Adherence of Streptococcus sanguis to conformationally specific determinants in fibronectin. Infect Immun (1988) 1.77

Synthetic peptides competitively inhibit both direct binding to fibroblasts and functional biological assays for the purified cell-binding domain of fibronectin. J Biol Chem (1985) 1.60

Granular pneumocytes in primary culture secrete several major components of the extracellular matrix. Biochemistry (1983) 1.47

Attachment of Pneumocystis carinii to rat pneumocytes. Lab Invest (1986) 1.47

Binding sites for streptococci and staphylococci in fibronectin. Infect Immun (1984) 1.41

Fibronectin receptors on Trypanosoma cruzi trypomastigotes and their biological function. Nature (1984) 1.38

Mechanism of pulmonary alveolar injury in experimental Pneumocystis carinii pneumonia in the rat. Br J Exp Pathol (1981) 1.35

Fibronectin in human bronchopulmonary lavage fluid. Elevation in patients with interstitial lung disease. J Clin Invest (1982) 1.31

In vitro parasite-monocyte interactions in human leishmaniasis: possible role of fibronectin in parasite attachment. Infect Immun (1985) 1.21

Trypanosoma cruzi infection inhibited by peptides modeled from a fibronectin cell attachment domain. Science (1986) 1.15

Attachment of Pneumocystis carinii to type I alveolar cells studied by freeze-fracture electron microscopy. Infect Immun (1983) 1.15

Amino acid sequence specificities of an adhesive recognition signal. J Cell Biochem (1985) 1.14

Interaction of Candida albicans with genital mucosal surfaces: involvement of fibronectin in adherence. J Infect Dis (1988) 1.03

Ultrastructural observations of Pneumocystis carinii attachment to rat lung. J Infect Dis (1985) 1.00

Scanning and transmission electron microscopic study of human pulmonary pneumocystosis. Chest (1977) 0.93

Glycoproteins of Pneumocystis carinii: characterization by electrophoresis and microscopy. J Infect Dis (1988) 0.92

Ultrastructural immunocytochemical localization of fibronectin in the developing rat lung. Cell Tissue Res (1983) 0.88

Anti-(Arg-Gly-Asp-Ser) antibody and its interaction with fibronectin, fibrinogen and platelets. Eur J Biochem (1988) 0.79

Impaired nociception and pain sensation in mice lacking the capsaicin receptor. Science (2000) 15.16

In vitro antimicrobial susceptibility of anaerobic bacteria isolated from clinical specimens. Antimicrob Agents Chemother (1972) 11.05

Evaluation of accuracy of multitest micromethod system for identification of Enterobacteriaceae. Appl Microbiol (1971) 10.28

Detection of human papilloma virus in paraffin-embedded tissue using the polymerase chain reaction. J Exp Med (1988) 9.10

Clinical utility of thoracoscopy. Chest (1992) 6.34

Practical method for isolation of anerobic bacteria in the clinical laboratory. Appl Microbiol (1971) 5.45

Identification of members of the family Enterobacteriaceae by the R-B system. Appl Microbiol (1970) 5.27

Comparison of three blood culture media for recovery of anaerobic bacteria. Appl Microbiol (1973) 5.22

Anaerobic bacteremia. Mayo Clin Proc (1972) 4.79

Microwave oven for melting laboratory media. J Clin Microbiol (1978) 4.33

Collaborative investigation of the AutoMicrobic System Enterobacteriaceae biochemical card. J Clin Microbiol (1980) 4.28

Evaluation of reagent-impregnated strips for identification of Enterobacteriaceae. Am J Med Technol (1971) 3.60

Isolation and indentification of anaerobic bacteria in the clinical laboratory. A 2-year experience. Mayo Clin Proc (1974) 3.54

Detection of cytomegalovirus DNA in peripheral blood of patients infected with human immunodeficiency virus. J Infect Dis (1988) 3.52

Cell to cell interaction in the immune response. IV. Site of action of antilymphocyte globulin. J Exp Med (1968) 3.16

Klebsiella in faecal flora of renal-transplant patients. Lancet (1970) 3.14

Evaluation of the enterotube system for identification of members of the family Enterobacteriaceae. Appl Microbiol (1971) 3.11

Evaluation of enrichment, storage, and age of blood agar medium in relation to its ability to support growth of anaerobic bacteria. J Clin Microbiol (1976) 3.09

Linkage between the poly-L-lysine gene and the locus controlling the major histocompatibility antigens in strain 2 guinea pigs. Proc Natl Acad Sci U S A (1970) 2.89

Biochemical and clinical characteristics and antibiotic susceptibility of atypical Enterobacter cloacae. Appl Microbiol (1969) 2.87

Pneumocystis carinii pneumonia. Differences in lung parasite number and inflammation in patients with and without AIDS. Am Rev Respir Dis (1989) 2.86

Evaluation of the Auxotab Enteric 1 System for identification of Enterobacteriaceae. Appl Microbiol (1972) 2.85

In vitro studies of piperacilin, a new semisynthetic penicillin. Antimicrob Agents Chemother (1978) 2.82

Clinical isolation of Yersinia enterocolitica: cold temperature enrichment. J Clin Microbiol (1975) 2.76

Genetic control of immune responsiveness to a glutamic acid, alanine, tyrosine copolymer in mice. I. Linkage of responsiveness to H-2 genotype. J Immunol (1971) 2.60

API and Minitek systems in identification of clinical isolates of anaerobic gram-negative bacilli and Clostridium species. J Clin Microbiol (1979) 2.54

Coagulase-negative staphylococcal bacteremia in patients receiving immunosuppressive therapy. Arch Intern Med (1983) 2.53

Epidemiologic significance of Klebsiella pneumoniae. A 3-month study. Mayo Clin Proc (1971) 2.51

Prevalence of serotypes of Salmonella. Appl Microbiol (1969) 2.50

Clinical and bacteriologic studies of anaerobic gram-positive cocci. Mayo Clin Proc (1972) 2.48

Diverticula of the Small Bowel. Ann Surg (1934) 2.44

Heamophilus vaginalis (Corynebacterium vaginal): method for isolation and rapid biochemical identification. Health Lab Sci (1977) 2.37

Bacteroides bacteremia. Minn Med (1970) 2.36

Bacterial (suppurative) arthritis in the adult. J Bone Joint Surg Am (1970) 2.26

Evaluation of the MS-2 system for rapid identification of Enterobacteriaceae. J Clin Microbiol (1980) 2.26

Rapid identification and antimicrobial susceptibility testing of gram-negative bacilli from blood cultures by the AutoMicrobic system. J Clin Microbiol (1981) 2.24

Comparative in vitro activity of moxalactam, cefotaxime, cefoperazone, piperacillin, and aminoglycosides against gram-negative bacilli. Antimicrob Agents Chemother (1980) 2.23

Markedly decreased expression of class I histocompatibility antigens, protein, and mRNA in human small-cell lung cancer. J Exp Med (1985) 2.12

Clinical evaluation of a lysis-centrifugation technique for the detection of septicemia. JAMA (1983) 2.12

Analysis of DNA sequences in forty-year-old paraffin-embedded thin-tissue sections: a bridge between molecular biology and classical histology. Cancer Res (1988) 2.06

Rapid detection of cytomegalovirus in bronchoalveolar lavage specimens by a monoclonal antibody method. J Clin Microbiol (1986) 2.05

Comparison of rates of virus isolation from leukocyte populations separated from blood by conventional and Ficoll-Paque/Macrodex methods. J Clin Microbiol (1979) 2.04

Hemagglutinin-specific cytotoxic T-cell response during influenza infection. J Exp Med (1977) 1.97

Clinical evaluation of the AutoMicrobic system Yeast Biochemical Card for rapid identification of medically important yeasts. J Clin Microbiol (1981) 1.94

Histocompatibility type and immune responsiveness in random bred Hartley strain guinea pigs. J Exp Med (1970) 1.90

Gram-negative rod bacteremia: microbiologic, immunologic, and therapeutic considerations. Ann Intern Med (1977) 1.90

Brain abscess with Corynebacterium hemolyticum: report of a case. Am J Clin Pathol (1971) 1.87

Non-radioactive single strand conformation polymorphism (SSCP) using the Pharmacia 'PhastSystem'. Nucleic Acids Res (1991) 1.86

Nosocomially acquired bacteriuria due to Proteus rettgeri and Providencia stuartii. Am J Clin Pathol (1973) 1.83

Serratia marcescens. Biochemical characteristics, antibiotic susceptibility patterns, and clinical significance. JAMA (1970) 1.80

In vitro susceptibility of gram-negative bacilli to gentamicin. Mayo Clin Proc (1970) 1.72

Cell-adhesive motif in region II of malarial circumsporozoite protein. Science (1990) 1.69

An analgesia circuit activated by cannabinoids. Nature (1998) 1.68

Anti-Salmonella agglutinins in chronic active liver disease. Lancet (1971) 1.67

Expression of yeast apurinic/apyrimidinic endonuclease (APN1) protects lung epithelial cells from bleomycin toxicity. Am J Respir Cell Mol Biol (2001) 1.63

In vitro studies with netilmicin compared with amikacin, gentamicin, and tobramycin. Antimicrob Agents Chemother (1977) 1.60

Enhanced immunogenicity of chemically-coated syngeneic tumor cells. Proc Natl Acad Sci U S A (1971) 1.55

120-kD surface glycoprotein of Pneumocystis carinii is a ligand for surfactant protein A. J Clin Invest (1992) 1.53

Specificity studies on cytotoxic thymus-derived lymphocytes reactive with influenza virus-infected cells: evidence for dual recognition of H-2 and viral hemagglutinin antigens. Proc Natl Acad Sci U S A (1977) 1.53

In vitro susceptibility of staphylococci and streptococci and influence of agar media on minimum inhibitory concentration. Mayo Clin Proc (1970) 1.53

Effects of medium and inoculum on antimicrobial susceptibility of anaerobic bacteria. Am J Clin Pathol (1974) 1.52

Clinical and bacteriologic observations on the proposed species, Enterobacter agglomerans (the Herbicola-Lathyri bacteria). Mayo Clin Proc (1972) 1.52

Site of action of antilymphocyte globulin. Lancet (1967) 1.51

Neutrophils kill pulmonary endothelial cells by a hydrogen-peroxide-dependent pathway. An in vitro model of neutrophil-mediated lung injury. Am Rev Respir Dis (1984) 1.50

Infections caused by Klebsiella ozaenae: a changing disease spectrum. J Clin Microbiol (1978) 1.50

Comparative in vitro synergistic activity of new beta-lactam antimicrobial agents and amikacin against Pseudomonas aeruginosa and Serratia marcescens. Antimicrob Agents Chemother (1981) 1.49

Detection of human papillomavirus in normal and dysplastic tissue by the polymerase chain reaction. Lab Invest (1988) 1.48

Interaction of vitronectin with Pneumocystis carinii: evidence for binding via the heparin binding domain. J Lab Clin Med (1995) 1.48

Cell-to-cell interaction in the immune response. VII. Requirement for differentiation of thymus-derived cells. J Exp Med (1971) 1.46

Oxidant injury of lung parenchymal cells. J Clin Invest (1981) 1.44

Recent Trends of Some Infectious Diseases. Br Med J (1942) 1.44

Simplified method of anaerobic incubation. Appl Microbiol (1971) 1.44

Cytomegalovirus infections associated with leukocyte transfusions. Ann Intern Med (1980) 1.44

Serum levels of interleukin-2 receptor and activity of rheumatic diseases characterized by immune system activation. Arthritis Rheum (1988) 1.41

Functional impairment of bronchoalveolar lavage phospholipids in early Pneumocystis carinii pneumonia in rats. J Lab Clin Med (1996) 1.41

Comparison of the Minitek test system with a conventional screening procedure for identification of Enterobacteriaceae. Health Lab Sci (1978) 1.40

Detection of human papillomavirus in formalin-fixed, invasive squamous carcinomas using the polymerase chain reaction. Am J Surg Pathol (1989) 1.40

Isolation of Plasmodium berghei (malaria) parasites by ammonium chloride lysis of infected erythrocytes. Nat New Biol (1971) 1.38

Rapid characterization of salmonella organisms by means of pyrolysis-gas-liquid chromatography. Anal Chem (1972) 1.35

Pneumocystis carinii: inhibition of lung cell growth mediated by parasite attachment. J Clin Invest (1990) 1.33

In vitro antibacterial activity of minocycline and effect of agar medium utilized in its susceptibility testing. Appl Microbiol (1970) 1.30

Yersinia enterocolitica: in vitro antimicrobial susceptibility. Antimicrob Agents Chemother (1978) 1.30

Fungal endophthalmitis following intraocular lens implantation. A surgical epidemic. Arch Ophthalmol (1980) 1.30

Pneumocystis carinii attachment to cultured lung cells by pneumocystis gp 120, a fibronectin binding protein. J Clin Invest (1991) 1.29

Comparison of media for isolation of salmonellae and shigellae from fecal specimens. Appl Microbiol (1971) 1.29

Assay for the immunosuppressive capacity of antilymphocyte serum. I. Evidence for opsonization. J Immunol (1969) 1.28

Hydrogen sulfide-negative variant of Citrobacter. Appl Microbiol (1970) 1.27

Comparison of Enteric-Tek with API 20E and conventional methods for identification of Enterobacteriaceae. J Clin Microbiol (1982) 1.24

The deoxyribonuclease test as applied to certain gram-negative bacteria. Can J Microbiol (1967) 1.23

Genetically engineered macrophages expressing IFN-gamma restore alveolar immune function in scid mice. Proc Natl Acad Sci U S A (2001) 1.20

Influenza A viruses of the H2N2 subtype are lymphocyte mitogens. Nature (1978) 1.20

Identification and characterization of novel mammalian neuropeptide FF-like peptides that attenuate morphine-induced antinociception. J Biol Chem (2001) 1.20

Mechanism of Pneumocystis carinii attachment to cultured rat alveolar macrophages. J Clin Invest (1990) 1.17

Assay for the immunosuppressive capacity of antilymphocyte serum based on its action on thymus-derived cells. Int Arch Allergy Appl Immunol (1969) 1.15

DNA of human papillomavirus type 16 in dysplastic and malignant lesions of the conjunctiva and cornea. N Engl J Med (1989) 1.14

Comparison of the BACTOMETER microbial monitoring system with conventional methods for detection of microorganisms in urine specimens. J Clin Microbiol (1977) 1.13

Interstitial lung disease. Assessment by bronchoalveolar lavage. Mayo Clin Proc (1983) 1.12

Immune surveillance directed against depressed cellular and viral alloantigens. Cell Immunol (1975) 1.11